Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis C Shrieve

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|June 20, 2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131Michael A Vogelbaum, Chen Hu, David M Peereboom, et al.
Journal of the American Academy of Dermatology|December 31, 2013
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalpBreanne E Terakedis, Christopher J Anker, Sancy A Leachman, et al.
Clinical Genitourinary Cancer|April 27, 2020
Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality RadiotherapyJonathan D Tward, Brock O'Neil, Ken Boucher, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|June 20, 2015
Phase II trial of pre-irradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: long term results of RTOG BR0131Michael A Vogelbaum, Chen Hu, David M Peereboom, et al.
Journal of the American Academy of Dermatology|December 31, 2013
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalpBreanne E Terakedis, Christopher J Anker, Sancy A Leachman, et al.
Clinical Genitourinary Cancer|April 27, 2020
Metastasis, Mortality, and Quality of Life for Men With NCCN High and Very High Risk Localized Prostate Cancer After Surgical and/or Combined Modality RadiotherapyJonathan D Tward, Brock O'Neil, Ken Boucher, et al.
Neuro-Oncology|February 21, 2018
Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group databaseDeborah T Blumenthal, Minhee Won, Minesh P Mehta, et al.
Neuro-Oncology|June 3, 2022
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539C Leland Rogers, Stephanie L Pugh, Michael A Vogelbaum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 27, 2026
Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk MeningiomaRupesh Kotecha, Mei-Yin Polley, Michael A Vogelbaum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 14, 2013
Central nervous system cancersLouis Burt Nabors, Mario Ammirati, Philip J Bierman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Central nervous system cancers, version 2.2014. Featured updates to the NCCN GuidelinesLouis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 5, 2020
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in OncologyLouis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2017
NCCN Guidelines Insights: Central Nervous System Cancers, Version 1.2017Louis Burt Nabors, Jana Portnow, Mario Ammirati, et al.
Pageof 10